Fidelta is a fee-for-service company, offering pre-clinical drug discovery services with a long history of successful drug discovery, including discovery of the blockbuster antibiotic, Azithromycin. Before joining the Galapagos Group in 2010, Fidelta was part of PLIVA and GSK.
For more information about Galapagos and Fidelta please visit www.glpg.com and www.fidelta.eu.